NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit

Tuesday, December 22, 2009 Heart Disease News
Email Print This Page Comment
Font : A-A+

Conference to Discuss the Latest Approaches in the Evaluation of Drugs that Affect Heart Rate, Blood Pressure, QT Prolongation and Other CV Safety Related Issues

Investor Contact:

Hayden IR

Jeff Stanlis, Partner and VP of Communications

(602) 476-1821

jeff@haydenir.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook